Drug intelligence / Profile preview

OMK-T

Development stage: Preclinical
Lead developer: Allegro
Modality: Fragment-Derived Small Molecules → Multivalent & Scaffold-Based Small Molecules → Small Molecules
Administration: Surgical Implant

Overview

OMK-T is a preclinical-stage artificial meniscus cartilage scaffold being developed by Allegro for the treatment of meniscus injuries. As a regenerative medicine candidate, OMK-T is designed to serve as a structural implant that mimics the natural biomechanical properties of meniscus cartilage, providing a framework for tissue repair and integration. The program is currently in the preclinical phase of development and utilizes advanced bio-fabrication technologies to create tissue-specific scaffolds.

Beyond the preview

Go deeper on OMK-T.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OMK-T.

Explore the full profile